Analyst Ratings published Monday November 18th 2024

11/18/24	Upgrades	Neutral Overweight	X
ACRS Aclaris Therapeutics Piper Sandler
$3 $13
11/18/24	Initiated	Buy	X
AKRO Akero Therapeutics Citigroup
$65
11/18/24	Upgrades	Neutral Outperform	X
AMLX Amylyx Pharmaceuticals Robert W. Baird
$3 $11
11/18/24	Upgrades	Neutral Buy	X
APD Air Products UBS
$375
11/18/24	Initiated	Overweight	X
ARVN Arvinas Stephens
$55
11/18/24	Reiterated	Buy	X
ATAI atai Life Sciences N.V. H.C. Wainwright
$15 $10
11/18/24	Upgrades	Neutral Buy	X
AUTL Autolus Therapeutics Goldman
$7 $7.60
11/18/24	Upgrades	Mkt Perform Outperform	X
BFAM Bright Horizons BMO Capital Markets
$137 $125
11/18/24	Downgrades	Buy Hold	X
BIIB Biogen Needham
11/18/24	Upgrades	Neutral Buy	X
BNS Bank of Nova Scotia UBS
11/18/24	Initiated	Outperform	X
BZ Kanzhun Limited CLSA
$18
11/18/24	Downgrades	Buy Neutral	X
CAR Avis Budget Northcoast
11/18/24	Upgrades	Hold Buy	X
CBRL Cracker Barrel Argus
$52
11/18/24	Initiated	Equal-Weight	X
CCCC C4 Therapeutics Stephens
$4
11/18/24	Resumed	Buy	X
COHR Coherent Citigroup
$106 $136
11/18/24	Initiated	Overweight	X
CPRX Catalyst Pharma Stephens
$35
11/18/24	Downgrades	Buy Hold	X
CR Crane Stifel
$176
11/18/24	Downgrades	Hold Underperform	X
CRL Charles River CLSA
$164
11/18/24	Upgrades	Eq Weight Overweight	X
CVS CVS Health Wells Fargo
$60 $66
11/18/24	Downgrades	Buy Hold	X
CW Curtiss-Wright Stifel
$370
11/18/24	Upgrades	Eq-Weight Overweight	X
DCOM Dime Community Stephens
$39
11/18/24	Downgrades	Overweight Neutral	X
EOG EOG Resources Piper Sandler
$147 $149
11/18/24	Initiated	Buy	X
ERAS Erasca Jefferies
$6
11/18/24	Downgrades	Buy Hold	X
ESAB ESAB Corp. Stifel
$138 $130
11/18/24	Downgrades	Buy Neutral	X
EYEN Eyenovia H.C. Wainwright
$12 $2
11/18/24	Upgrades	Underperform Neutral	X
FATE Fate Therapeutics BofA Securities
11/18/24	Downgrades	Outperform Mkt Perform	X
FBK FB Financial Hovde Group
$60
11/18/24	Upgrades	Hold Buy	X
FNV Franco-Nevada Canaccord Genuity
11/18/24	Initiated	Buy	X
FNV Franco-Nevada UBS
$160
11/18/24	Initiated	Outperform	X
FTI TechnipFMC RBC Capital Mkts
$37
11/18/24	Downgrades	Buy Hold	X
FTV Fortive Argus
11/18/24	Upgrades	Eq-Weight Overweight	X
FUTU Futu Holdings Morgan Stanley
$70 $115
11/18/24	Initiated	Buy	X
GATX GATX Goldman
$185
11/18/24	Upgrades	Hold Buy	X
HOOD Robinhood Markets Needham
$40
11/18/24	Upgrades	Outperform Strong Buy	X
HPE Hewlett Packard Enterprise Raymond James
$23 $29
11/18/24	Initiated	Overweight	X
IDYA IDEAYA Biosciences Stephens
$51
11/18/24	Downgrades	Buy Hold	X
IR Ingersoll-Rand Stifel
$112 $107
11/18/24	Initiated	Overweight	X
KYMR Kymera Therapeutics Stephens
$65
11/18/24	Downgrades	Buy Neutral	X
LBTYA Liberty Global UBS
$23 $13
11/18/24	Downgrades	Outperform Peer Perform	X
MATX Matson Wolfe Research
11/18/24	Upgrades	Mkt Perform Outperform	X
MBI MBIA Keefe Bruyette
$6.50 $9
11/18/24	Upgrades	Hold Buy	X
MPWR Monolithic Power Loop Capital
$660
11/18/24	Upgrades	Hold Buy	X
MRNA Moderna HSBC Securities
$58
11/18/24	Downgrades	Outperform Mkt Perform	X
NBHC National Bank Hovde Group
$55
11/18/24	Downgrades	Buy Hold	X
PH Parker-Hannifin Stifel
$691
11/18/24	Downgrades	Outperform Mkt Perform	X
PNFP Pinnacle Finl Hovde Group
$135
11/18/24	Downgrades	Overweight Eq Weight	X
PNW Pinnacle West Barclays
$93 $91
11/18/24	Initiated	Outperform	X
POET POET Technologies Northland Capital
$6
11/18/24	Downgrades	Neutral Sell	X
RDFN Redfin Goldman
$6 $6.50
11/18/24	Upgrades	Neutral Outperform	X
ROKU Roku Robert W. Baird
$70 $90
11/18/24	Resumed	Neutral	X
RXO RXO, Inc. Goldman
$29
11/18/24	Initiated	Neutral	X
TRN Trinity Industries Goldman
$39
11/18/24	Upgrades	Underweight Neutral	X
UFCS United Fire Group Piper Sandler
$19 $26
11/18/24	Initiated	Buy	X
WPM Wheaton Precious Metals UBS
$78
11/18/24	Initiated	Outperform	X
YMAB Y-mAbs Therapeutics Oppenheimer
$23